Detection and characterization of hepatitis E virus genotype 3 in HIV-infected patients and blood donors from southern Brazil

• Main Authors: Cláudio Moss da Silva, Jaqueline Mendes Oliveira, Raúl Andrés Mendoza-Sassi, Andreza Soriano Figueiredo, Luísa Dias da Mota, Maíba Mikhael Nader, Noemi Rovaris Gardinali, Yohan Britto Kevorkian, Sarah Beatriz Salamene Salvador, Marcelo Alves Pinto, Ana Maria Barral Martinez
• Format: Article
• Language: English
• Published: Elsevier 2019-09-01
• Series: International Journal of Infectious Diseases
• Online Access: http://www.sciencedirect.com/science/article/pii/S1201971219302723

Background: Hepatitis E virus genotype 3 (HEV-3) infection usually causes self-limited acute hepatitis. In immunosuppressed patients, HEV-3 infection can rapidly progress to chronic hepatitis and cirrhosis. In southern Brazil, data on HEV seroprevalence are scarce. Methods: Testing for HEV RNA and antibodies (anti-HEV) was performed for 320 HIV-infected patients followed at the HIV/AIDS Service of the Federal University of Rio Grande between 2012 and 2013, as well as 281 blood donor samples obtained in 2015. Variables associated with anti-HEV positivity were assessed by multivariable logistic regression analysis. Results: HIV and blood donor groups showed similar HEV seroprevalence (6.7% and 7.1%, respectively). Risk factors associated with anti-HEV detection were older age, marital status, a higher number of sexual partners, poor sanitation, and alcohol use (HIV group), and living in a rural area (blood donors). HEV RNA was detected in eight serum samples from HIV-infected patients and in one blood donor, who was also positive for anti-HEV IgM and IgG. Conclusions: The prevalence rates of HEV infection were comparable between HIV-seropositive patients who were not severely immunocompromised and blood donors. The blood donor’s HEV isolate showed high similarity with swine HEV strains from Brazilian herds in the same region, thus indicating a potential risk of foodborne and parenteral transmission via blood transfusion. Keywords: Hepatitis E virus, HEV, Seroprevalence, HEV RNA, HIV, Blood donors